As an exponentially growing market with significant value to the general public, in-vitro diagnostics are increasingly being considered as not only an indispensable tool for medical diagnoses but also as decision-making aids for disease prevention and timely treatment. Pertaining to its utmost importance in the global healthcare industry, the IVD market—comprising analysers, reagents, disposable and reusable products, and accessory software products used by both clinical and research laboratories around the world—has become the highest revenue segment of the medical device market, valued in the multi-billion-dollar range.
Especially amid the backdrop of a pandemic, companies have shifted their focus to molecular diagnostics and testing, leading to a steep rise in the demand for RT-PCR procedures, assays, kits, and reagents, as these diagnostic technologies offer results in less time.
At the same time, industry trends that are grounded in rapid disease identification, personalized care for patients, and the advanced use of analytics are compelling medical device manufacturers to expand the current scope of IVD technologies. Among them, the technologies that are most heavily influenced by these trends, point-of-care (POC), liquid biopsy, molecular diagnostics, happen to take the top spot
in terms of demand. Alongside, artificial intelligence (AI), and the Internet of Things (IoT)— the two grand pillars of the Fourth Industrial Revolution, are being increasingly deployed in conjunction with in-vitro diagnostics.
Against this backdrop, in cognizance of the transformative period for the IVD market, a distinguished panel comprising CEOs, CIOs, VCs, along with the editorial board of MedTech Outlook, has compiled a list of leading IVD solution providers that can help healthcare providers perform in-vitro diagnostics more efficiently.
We present to you MedTech Outlook’s “Top 5 In Vitro Diagnostic Solution Companies in UK — 2021.”
